期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Unveiling the role of Pafah1b3 in liver fibrosis:A novel mechanism revealed 被引量:1
1
作者 Lifan Lin Shouzhang Yang +2 位作者 Xinmiao Li Weizhi Zhang Jianjian Zheng 《Journal of Pharmaceutical Analysis》 2025年第1期230-243,共14页
Liver fibrosis is a common outcome of various chronic hepatic insults,characterized by excessive extracellular matrix(ECM)deposition.The precise mechanisms,however,remain largely undefined.This study identified an ele... Liver fibrosis is a common outcome of various chronic hepatic insults,characterized by excessive extracellular matrix(ECM)deposition.The precise mechanisms,however,remain largely undefined.This study identified an elevated expression of platelet-activating factor acetylhydrolase 1B3(Pafah1b3)in liver tissues from both carbon tetrachloride(CCl_(4))-treated mice and patients with cirrhosis.Deletion of Pafah1b3 significantly attenuated CCl_(4)-induced fibrosis,hepatic stellate cell(HSC)activation,and activation of transforming growth factor-β(TGF-β)signaling.Mechanistically,PAFAH1B3 binds to mothers against decapentaplegic homolog 7(SMAD7),disrupting SMAD7's interaction with TGF-βreceptor 1(TβR1),which subsequently decreases TbR1 ubiquitination and degradation.Pharmacological inhibition using 3-IN-P11,a specific Pafah1b3 inhibitor,conferred protective effects against CCl_(4)-induced fibrosis in mice.Furthermore,Pafah1b3 deficiency reduced hepatic inflammation.Overall,these results establish a pivotal role for Pafah1b3 in modulating TGF-βsignaling and driving HSC activation. 展开更多
关键词 platelet-activating factor acetylhydrolase 1B3 Liver fibrosis Transforming growth factor-βsignaling Hepatic stellate cells UBIQUITINATION
暂未订购
USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells 被引量:2
2
作者 Sheng-Liang Xin Xiao-Li Pan +1 位作者 Xiao-Yuan Xu Yan-Yan Yu 《Journal of Clinical and Translational Hepatology》 SCIE 2023年第1期45-57,共13页
Background and Aims:Nonalcoholic fatty liver disease(NAFLD)is a common chronic liver disease caused by overnutrition.Impaired autophagy is closely related to NAFLD progression.Recently,ubiquitin-specific peptidase-10(... Background and Aims:Nonalcoholic fatty liver disease(NAFLD)is a common chronic liver disease caused by overnutrition.Impaired autophagy is closely related to NAFLD progression.Recently,ubiquitin-specific peptidase-10(USP10)was reported to ameliorate hepatic steatosis,but the underlying mechanism is still unclear.In view of the potential effects of USP10 on autophagy,we investigated whether USP10 alleviated steatosis through autophagy.Methods:HepG2 cells were treated with palmitic acid(PA)to model NAFLD in vitro.Lentivirus was used to regulate USP10 level in cells.Autophagic regulators were used to autophagic progression in cells.Western blotting,real-time fluorescence quantitative polymerase chain reaction,lipid drop staining and immunofluorescent staining were performed to determine the effect of USP10 on lipid autophagy.Student’s t-test and Tukey’s post hoc test were used to compare the means among groups.Results:PA induced cellular steatosis with dependance on autophagy.USP10 overexpression alleviated PA-induced steatosis,restored autophagic activity,promoted autophagic flux,including synthesis and degradation of autophagosomes,and lipid-targeted autophagy.In the presence of autophagy inhibitors,the protective effectiveness of USP10 on steatosis decreased.Furthermore,the specific inhibitor to C-jun N-terminal protein kinase-1(JNK1),DB07268,abolished USP10-induced autophagy.However,during early stage inhibition of JNK1,compensatory expression of tuberous sclerosis complex-2(TSC2)maintained autophagy.The degree of TSC2-to-JNK1 compensation was positively associated with USP10 level.Functionally,JNK1 and TSC2 were involved in the lipid-lowering effect of USP10.Conclusions:USP10 alleviated hepatocellular steatosis in autophagy-dependent manner.JNK1/TSC2 signaling pathways were required for USP10-induced autophagy. 展开更多
关键词 AUTOPHAGY Nonalcoholic fatty liver disease STEATOSIS Ubiquitinspecific peptidase-10 C-jun N-terminal protein kinase-1 Tuberous sclerosis complex-2
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部